Endothelin receptor antagonists prevent parathyroid cell proliferation caused by hypocalcemia in rats

Current Opinion in Nephrology and Hypertension

Volumn 11, Issue 4, 2002, Pages 411-415

  Kitamura, Kenichiro ^a   Tomita, Kimio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell proliferation; Endothelin receptor antagonists; Parathyroid gland; Secondary hyperparathyroidism

Indexed keywords

BOSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; PARATHYROID HORMONE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM HOMEOSTASIS; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; HYPERPARATHYROIDISM; HYPOCALCEMIA; NONHUMAN; PARATHYROID CELL; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; SECONDARY HYPERPARATHYROIDISM; ANIMAL; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; PARATHYROID GLAND; PATHOLOGY; PHYSIOLOGY;

ANIMAL; CELL DIVISION; ENDOTHELIN-1; HYPOCALCEMIA; MITOGENS; PARATHYROID GLANDS; RATS; RECEPTORS, ENDOTHELIN; ANIMALS;

EID: 0036019485     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200207000-00007     Document Type: Review

References (36)

1. Renal osteodystrophy
2. Parathyroid growth, normal and abnormal
3. The basal rate of cell proliferation in normal human parathyroid tissue: Implications for the pathogenesis of hyperparathyroidism
4. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo
5. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat
6. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D
7. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells
8. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells
9. Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression
10. The parathyroid glands in the rat as seen by ultrathin step and serial sectioning
11. Parathyroid cell number and size in hypocalcemic young rats
12. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro
13. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells
14. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro
15. Endothelin system: The double-edged sword in health and disease
16. Activation of multiple mitogen-activated protein kinase signal transduction pathways by the endothelin B receptor requires the cytoplasmic tail
17. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
18. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop
19. Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cells
20. Endothelin-1 stimulates its own synthesis in human endothelial cells
21. Autocrine regulation of the endothelin-1 gene in rat endothelial cells
22. Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure
23. Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats
24. Endothelin as an autocrine factor in the regulation of parathyroid cells
25. Endothelin receptors in human parathyroid gland
26. Do we need endothelin antagonists?
27. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
28. Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats
29. B receptor antagonist
30. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
31. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
32. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
33. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease
34. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
35. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol
36. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia